Company: ZURA
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-110793
Chunk: 4

Company: Zura Bio Ltd
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1F
Chunk 4
---
Item 1. Financial Statements.

Zura Bio Limited

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands, except share data)

​​​​​​​​    September 30,     December 31, ​​2025​2024​​(unaudited)​​​Assets​​​​​​Current assets ​​​​  Cash and cash equivalents​$ 139,017​$ 176,498Prepaid expenses and other current assets​​ 3,275​​ 2,246Total current assets​​ 142,292​​ 178,744Property and equipment, net​​ 131​​ 91Other assets​​ 1,512​​ 698Total assets​$ 143,935​$ 179,533​​​​​​​Liabilities, Redeemable Noncontrolling Interest and Shareholders’ Equity​​​​​​Current liabilities​​​​​​Accounts payable and accrued expenses​$ 25,491​$ 19,514Total current liabilities​​ 25,491​​ 19,514Total liabilities​​ 25,491​​ 19,514​​​​​​​Commitments and contingencies (Note 9)​​​​​​​​​​​​​Redeemable noncontrolling interest​​ 8,660​​ 11,663​​​​​​​Shareholders’ Equity​​​​​​Preferred shares, $0.0001 par value, 1,000,000 shares authorized as of September 30, 2025 and December 31, 2024; no shares issued and outstanding as of September 30, 2025 and December 31, 2024​​—​​—Class A Ordinary Shares, $0.0001 par value; 300,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 65,018,058 and 65,297,530 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively​​ 7​​ 7Additional paid-in capital​​ 315,608​​ 302,705Accumulated deficit​​ (207,372)​​ (155,897)Total Zura Bio Limited shareholders’ equity ​​ 108,243​​ 146,815Noncontrolling interest​​ 1,541​​ 1,541Total shareholders’ equity ​​ 109,784​​ 148,356Total liabilities, redeemable noncontrolling interest and shareholders’ equity ​$ 143,935​